New York, NY, March 5, 2015 — JDRF, the leading research and advocacy organization funding type 1 diabetes (T1D) research announced today a new research partnership with the European Foundation for the Study of Diabetes (EFSD) and Eli Lilly and Company to establish a new research funding program to accelerate type 1 diabetes discovery and translational research. Each organization will contribute to supporting the new three-year research initiatives that spans the full breadth of the JDRF research portfolio and is aligned with JDRF’s research objectives.
↧